Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Ozempic could be behind a “concerning” return of skinny models, the editor of British Vogue magazine has said. Chioma Nnadi ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

We're living in a world full of foods that trigger constant hunger, cravings and thoughts about eating. Is it even possible ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

GLP-1s seem to be everywhere. The appetite suppressant drugs, with brand names like Ozempic and Wegovy, have grown in ...

Regulatory watchdog South African Health Products Regulatory Authority said these types of products pose a health risk to the public.

GLP-1 agonists – of which Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide) are the most ...

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...